Mansharamani et al. have suggested that a cut-off value of 300 CD4+ cells/μL would include 91% of PJP cases among HIV-negative patients, which is a high-risk group, although 39–46% of individuals who received long-term corticosteroid therapy also had CD4+ counts of <300/μL33. Here, CD4 is linked to pneumocystosis.